Interestingly, IGFBP3 has been reported to act as a suppressor of vascular endothelial growth factor (VEGF) in SCCHN angiogenesis [16] and to be downregulated in the early phases of head and neck carcinogenesis [30]. Here, VEGFA is linked to head and neck squamous cell carcinoma.